Literature DB >> 7974130

Full recovery from deafness after removal of a large acoustic neurinoma associated with neurofibromatosis 2: case report.

T Kawaguchi1, R Tanaka, S Kameyama, H Yamazaki.   

Abstract

The first case of full recovery from deafness after radical intracapsular removal of a large acoustic neurinoma, more than 4 cm in diameter, is reported. The patient, a 17-year-old woman, had multiple intracranial and intraspinal tumors in addition to bilateral acoustic neurinomas. Radical intracapsular removal is a useful technique to preserve nerves in patients with large acoustic neurinoma. When identifiable evoked potentials are preserved in brain stem auditory evoked potential, hearing preservation should be tried despite preoperative hearing level.

Entities:  

Mesh:

Year:  1994        PMID: 7974130     DOI: 10.1016/0090-3019(94)90403-0

Source DB:  PubMed          Journal:  Surg Neurol        ISSN: 0090-3019


  4 in total

1.  Clinical features of vestibular schwannomas in patients who experience hearing improvement after surgery.

Authors:  Michihiro Kohno; Shigeo Sora; Hiroaki Sato; Masanobu Shinogami; Hidehiko Yoneyama
Journal:  Neurosurg Rev       Date:  2014-12-21       Impact factor: 3.042

2.  Different aspects of hearing preservation in surgery of vestibular schwannoma in women and men.

Authors:  B Schaller; R Probst; O Gratzl; J A Rem; R Hauser; M Tolnay
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

Review 3.  Hearing improvement after vestibular schwannoma surgery in the era of the hearing preservation rule - case report and literature review.

Authors:  Zdenek Fik; Jan Lazak; Silvie Hruba; Zdenek Cada; Eduard Zverrna; Jan Betka
Journal:  Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub       Date:  2021-12-09       Impact factor: 1.648

4.  Long-term follow-up of the residual intracanalicular tumours after subtotal removal of acoustic neurinomas.

Authors:  S Kameyama; R Tanaka; T Kawaguchi; Y Honda; H Yamazaki; A Hasegawa
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.